Skip to main content
. Author manuscript; available in PMC: 2011 Feb 2.
Published in final edited form as: Mol Cancer Ther. 2010 Feb 2;9(2):438. doi: 10.1158/1535-7163.MCT-09-0682

Figure 3. MT-mTer and MT-mTer/siRNA inhibit E4 mouse prostate cancer proliferation in vitro.

Figure 3

Cell growth by MTS colorimetric cell viability assay is significantly inhibited by day 7 after expression of MT-mTer or MT-mTer/siRNA constructs (50% and 90% reduction, respectively).